TABLE 2.
WHI RCTa (50 – 79 yrs) |
WHI RCTb (50 – 70 yrs) |
WHI RCTb (50 – 59 yrs) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Treated | Placebo | HR (95% CI) | Treated | Placebo | HR (95% CI) | Treated | Placebo | HR (95% CI) | |
Estrogen only | Estrogen only | Estrogen only | |||||||
(n) | 5310 | 5429 | 4024 | 4128 | 1637 | 1673 | |||
CHD | 177 | 199 | 0.91 [0.75–1.12] | 117 | 140 | 0.86 [0.67–1.11] | 21 | 34 | 0.63 [0.36–1.09] |
CVA | 158 | 118 | 1.39 [1.10–1.77] | 102 | 75 | 1.40 [1.03–1.91] | 18 | 21 | 0.89 [0.47–1.69] |
DEATH | 291 | 289 | 1.04 [0.88–1.22] | 163 | 179 | 0.94 [0.75–1.16] | 34 | 48 | 0.71 [0.46–1.11] |
GPRD STUDYc (55 – 79 yrs) |
GPRD STUDYc (50 – 55 yrs) |
||||||||
Exp | UnExp | Adj HR (95% CI) | Exp | UnExp | Adj HR (95% CI) | ||||
Estrogen only | Estrogen only | ||||||||
(n) | 6890 | 11,572 | 6842 | 9624 | |||||
MI | 59 | 238 | 0.50 [0.38–0.67]d | 39 | 66 | 0.85 [0.57–1.37]f | |||
CVA | 93 | 191 | 0.95 [0.74–1.23]e | 52 | 72 | 1.10 [0.76–1.58]g | |||
DEATH | 182 | 497 | 0.68 [0.57–0.81] | 65 | 169 | 0.53 [0.40–0.71] |